C-Arm Cone Beam Computed Tomography for Stroke, Acute, Stroke Ischemic

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Wisconsin, Madison, Madison, WI
Stroke, Acute, Stroke Ischemic+1 More
C-Arm Cone Beam Computed Tomography - DiagnosticTest
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The study objective for the Phase 2 of this research is to demonstrate and confirm the substantial time savings that can be obtained using cone beam computed tomography (CB-CT) for both complete image acquisition and rapid image reconstruction in a Direct to Angio paradigm (One Stop Shop) for selected acute ischemic stroke (AIS) patients.

Eligible Conditions

  • Stroke, Acute, Stroke Ischemic

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Stroke, Acute, Stroke Ischemic

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 1 visit (up to 120 minutes)

1 visit (up to 120 minutes)
Feasibility measured as the amount of time from hospital arrival to the angiography suite

Trial Safety

Safety Progress

1 of 3

Other trials for Stroke, Acute, Stroke Ischemic

Trial Design

2 Treatment Groups

MD-CT
1 of 2
C-ARM CBCT
1 of 2
Active Control
Experimental Treatment

90 Total Participants · 2 Treatment Groups

Primary Treatment: C-Arm Cone Beam Computed Tomography · No Placebo Group · N/A

C-ARM CBCT
DiagnosticTest
Experimental Group · 1 Intervention: C-Arm Cone Beam Computed Tomography · Intervention Types: DiagnosticTest
MD-CT
DiagnosticTest
ActiveComparator Group · 1 Intervention: Multi-detector Computed Tomography · Intervention Types: DiagnosticTest
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
C-Arm Cone Beam Computed Tomography
2017
N/A
~60

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 visit (up to 120 minutes)
Closest Location: University of Wisconsin, Madison · Madison, WI
Photo of madison  1Photo of madison  2Photo of madison  3
2011First Recorded Clinical Trial
2 TrialsResearching Stroke, Acute, Stroke Ischemic
24 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are of childbearing potential.
The NIHSS is a test that can be used to assess the severity of a stroke.
You have no severe co-morbidities.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.